JP2015119730A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015119730A5 JP2015119730A5 JP2015055989A JP2015055989A JP2015119730A5 JP 2015119730 A5 JP2015119730 A5 JP 2015119730A5 JP 2015055989 A JP2015055989 A JP 2015055989A JP 2015055989 A JP2015055989 A JP 2015055989A JP 2015119730 A5 JP2015119730 A5 JP 2015119730A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- seq
- sequence
- segment
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605922P | 2012-03-02 | 2012-03-02 | |
| US61/605,922 | 2012-03-02 | ||
| US201261685766P | 2012-03-23 | 2012-03-23 | |
| US61/685,766 | 2012-03-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Division JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015119730A JP2015119730A (ja) | 2015-07-02 |
| JP2015119730A5 true JP2015119730A5 (https=) | 2016-10-13 |
| JP6279503B2 JP6279503B2 (ja) | 2018-02-14 |
Family
ID=47997362
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Active JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
| JP2015055989A Active JP6279503B2 (ja) | 2012-03-02 | 2015-03-19 | インフルエンザウイルスの再集合 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Active JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9422528B2 (https=) |
| EP (1) | EP2820126B1 (https=) |
| JP (2) | JP6054883B2 (https=) |
| CN (1) | CN103608453B (https=) |
| AU (1) | AU2013205478B9 (https=) |
| CA (1) | CA2813723A1 (https=) |
| ES (1) | ES2628301T3 (https=) |
| WO (1) | WO2013087945A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| ES2655051T3 (es) | 2011-08-26 | 2018-02-16 | Wisconsin Alumni Research Foundation | Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas |
| US20140274806A1 (en) | 2013-03-15 | 2014-09-18 | Synthetic Genomics Vaccines | Influenza virus reassortment |
| MX2015009330A (es) * | 2013-01-23 | 2016-04-15 | Novartis Ag | Reordenamiento del virus de influenza. |
| CA2914604A1 (en) * | 2013-06-06 | 2014-12-11 | Novartis Ag | Influenza virus reassortment |
| WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| RU2605317C1 (ru) * | 2015-06-04 | 2016-12-20 | Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) | АДАПТИРОВАННЫЕ ПАНДЕМИЧЕСКИЕ ШТАММЫ ВИРУСА ГРИППА A/Tomsk/273/2010-MA1(H1N1pdm09), A/Tomsk/273/2010-MA2(H1N1pdm09) И A/Tomsk/273/2010-MA3(H1N1pdm09) ДЛЯ ОЦЕНКИ ДЕЙСТВИЯ ПРОТИВОВИРУСНЫХ ПРЕПАРАТОВ (ВАРИАНТЫ) |
| HK1254344A1 (zh) | 2015-06-26 | 2019-07-19 | Seqirus UK Limited | 抗原匹配的流感疫苗 |
| HUE051783T2 (hu) | 2015-07-07 | 2021-03-29 | Seqirus Uk Ltd | Eljárás immunogén hemagglutinin mennyiségi meghatározására |
| WO2017040203A1 (en) * | 2015-08-28 | 2017-03-09 | Yoshihiro Kawaoka | Generation of infectious influenza viruses from virus-like particles |
| CA3014435C (en) | 2016-02-19 | 2023-04-18 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza b virus replication for vaccine development |
| CN109312310B (zh) | 2016-07-15 | 2022-08-02 | 一般财团法人阪大微生物病研究会 | 重配流感病毒的制备方法 |
| CN111032861B (zh) * | 2017-08-28 | 2023-09-12 | 一般财团法人阪大微生物病研究会 | 重配流感病毒的阶段性制备方法 |
| WO2019084310A1 (en) | 2017-10-25 | 2019-05-02 | Yoshihiro Kawaoka | HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION |
| MX2020004151A (es) | 2017-10-30 | 2020-08-13 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos. |
| US12343390B2 (en) | 2018-08-07 | 2025-07-01 | Wisconsin Alumni Research Foundation (Warf) | Recombinant biologically contained filovirus vaccine |
| JP7655849B2 (ja) | 2018-08-20 | 2025-04-02 | ウィスコンシン アルムニ リサーチ ファンデイション | ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター |
| WO2020163804A1 (en) | 2019-02-08 | 2020-08-13 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
| US11390649B2 (en) | 2019-05-01 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
| US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
| WO2021150874A1 (en) | 2020-01-24 | 2021-07-29 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized na |
| US12290562B2 (en) | 2020-03-25 | 2025-05-06 | Wisconsin Alumni Research Foundation (Warf) | Recombinant multivalent influenza viruses |
| JP7779858B2 (ja) * | 2020-04-29 | 2025-12-03 | エスケー バイオサイエンス カンパニー リミテッド | 使い捨て培養工程システムを用いたインフルエンザウイルス生産方法及びインフルエンザウイルス抗原精製条件の迅速確認試験 |
| US11694876B2 (en) | 2021-12-08 | 2023-07-04 | Applied Materials, Inc. | Apparatus and method for delivering a plurality of waveform signals during plasma processing |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| WO1995011700A1 (en) | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| ATE384126T1 (de) | 1998-06-12 | 2008-02-15 | Sinai School Medicine | Interferon induzierende genetisch veränderte attenuierte viren |
| TR200200776T2 (tr) | 1999-09-24 | 2002-06-21 | Smithkline Beecham Biologicals S.A. | Burun içi grip virüsü aşısı. |
| JP4698112B2 (ja) | 2000-03-03 | 2011-06-08 | 一般財団法人化学及血清療法研究所 | 無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法 |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| ATE503493T1 (de) | 2001-02-23 | 2011-04-15 | Glaxosmithkline Biolog Sa | Influenza vakzinzusammensetzungen zur intradermaler verabreichung |
| JP2004536785A (ja) | 2001-02-23 | 2004-12-09 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規なワクチン |
| TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
| AU2004249133B2 (en) * | 2003-05-28 | 2009-05-28 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
| AU2005230708B2 (en) | 2004-04-05 | 2009-01-15 | Zoetis Services Llc | Microfluidized oil-in-water emulsions and vaccine compositions |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| NZ551640A (en) | 2004-05-20 | 2010-05-28 | Id Biomedical Corp | Process for the production of an influenza vaccine |
| ATE547511T1 (de) | 2004-12-23 | 2012-03-15 | Medimmune Llc | Nichttumorbildende mdck-zellinie zur vermehrung von viren |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| RU2008101367A (ru) | 2005-06-21 | 2009-08-10 | Медиммун, Ллк (Us) | Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| CA2627971A1 (en) | 2005-11-01 | 2007-05-10 | Novartis Vaccines And Diagnostics Gmbh & Co Kg. | Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment |
| WO2007052061A2 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| WO2007126810A2 (en) * | 2006-03-31 | 2007-11-08 | Warf - Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| PT2016194E (pt) | 2006-04-19 | 2015-07-20 | Medimmune Llc | Métodos e composições para expressar arn viral de polaridade negativa em células caninas |
| KR101151202B1 (ko) | 2006-10-12 | 2012-06-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 수중유 에멀젼 애주번트를 포함하는 백신 |
| SG177141A1 (en) | 2006-12-06 | 2012-01-30 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
| EP2045323A1 (en) | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| JP5686741B2 (ja) * | 2008-12-16 | 2015-03-18 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | インフルエンザワクチンの生成 |
| EP2233152A1 (en) * | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | High growth reassortant influenza A virus |
| WO2011012999A1 (en) | 2009-07-31 | 2011-02-03 | Novartis Ag | Reverse genetics systems |
| EP2493912B1 (en) * | 2009-10-26 | 2020-07-29 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in vero cells |
| ES2655051T3 (es) * | 2011-08-26 | 2018-02-16 | Wisconsin Alumni Research Foundation | Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas |
-
2013
- 2013-03-02 EP EP13712156.2A patent/EP2820126B1/en active Active
- 2013-03-02 ES ES13712156.2T patent/ES2628301T3/es active Active
- 2013-03-02 CN CN201380000396.3A patent/CN103608453B/zh active Active
- 2013-03-02 JP JP2013548864A patent/JP6054883B2/ja active Active
- 2013-03-02 AU AU2013205478A patent/AU2013205478B9/en active Active
- 2013-03-02 CA CA2813723A patent/CA2813723A1/en not_active Abandoned
- 2013-03-02 WO PCT/EP2013/054227 patent/WO2013087945A2/en not_active Ceased
- 2013-06-03 US US13/909,013 patent/US9422528B2/en active Active
-
2015
- 2015-03-19 JP JP2015055989A patent/JP6279503B2/ja active Active
-
2016
- 2016-07-14 US US15/210,485 patent/US10245312B2/en active Active
-
2019
- 2019-02-11 US US16/272,018 patent/US20200000909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015119730A5 (https=) | ||
| JP7691380B2 (ja) | Ｍｄｃｋ、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス | |
| JP2016521553A5 (https=) | ||
| EP1631663B1 (en) | High titer recombinant influenza viruses for vaccines and gene therapy | |
| JP2016509864A5 (https=) | ||
| Szewczyk et al. | Introduction to molecular biology of influenza a viruses. | |
| EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
| EP2010557B1 (en) | High titer recombinant influenza viruses for vaccines | |
| JP2011182797A5 (https=) | ||
| US20140227310A1 (en) | Recombinant influenza virus highly expressing ha protein and preparation method and use thereof | |
| JP2016501020A5 (https=) | ||
| Jang et al. | Principles underlying rational design of live attenuated influenza vaccines | |
| US20190203170A1 (en) | Avian Cells for Improved Virus Production | |
| CN104232594B (zh) | 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 | |
| JP2014506785A5 (https=) | ||
| TWI396741B (zh) | 非洲綠猴腎細胞培養之流感病毒及疫苗 | |
| AU2013298632B2 (en) | Production of infectious influenza viruses | |
| CN105671002A (zh) | H9n2亚型禽流感病毒细胞高产疫苗株构建及应用 | |
| Gong et al. | Epitope variation in the Newcastle disease virus HN gene under antibody immune selective pressure in cell culture | |
| CN102234637A (zh) | 重组甲型h1n1流感病毒灭活疫苗株(sc/pr8)的制备及应用 | |
| Zhang et al. | A chimeric Ad5-Envp-VLP vaccine platform confers broad-spectrum immunity against emerging and re-emerging pathogens | |
| Hartgroves et al. | Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs | |
| JP6748067B2 (ja) | インフルエンザウイルス作出用細胞 | |
| van Wielink et al. | Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells | |
| HK40060079B (zh) | 高生长流感病毒 |